Multimodality therapy for esophageal cancer

Research output: Contribution to journalArticlepeer-review

Abstract

Over the past decade and a half, several strategies have been developed to improve the survival of patients with esophageal cancer. Two strategies employ either neoadjuvant chemotherapy or chemoradiotherapy followed by surgery to improve local-regional control and decrease the incidence of distant metastases. A third strategy uses nonsurgical therapy as definitive treatment for patients without metastatic disease. Single-institution pilot thais and randomized comparative trials have been conducted evaluating each approach. The rationale for these thais, results, and current recommendations are presented.

Original languageEnglish (US)
Pages (from-to)195S-200S
JournalCHEST
Volume112
Issue number4 SUPPL.
DOIs
StatePublished - Jan 1 1997

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Multimodality therapy for esophageal cancer'. Together they form a unique fingerprint.

Cite this